113 related articles for article (PubMed ID: 7843123)
1. Monoisoamyl meso-2,3-dimercaptosuccinate as a delayed treatment for mercury removal in rats.
Kostial K; Kargacin B; Blanusa M; Piasek M; Jones MM; Singh PK
Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):309-11. PubMed ID: 7843123
[TBL] [Abstract][Full Text] [Related]
2. Superiority of Mi-ADMS to DMSA as parenteral treatment for decreasing mercury (203Hg) body burden in rats.
Kostial K; Blanusa M; Piasek M; Simonović I; Jones MM; Singh PK
Arh Hig Rada Toksikol; 1993 Sep; 44(3):217-22. PubMed ID: 8311694
[TBL] [Abstract][Full Text] [Related]
3. Monoisoamyl and mono-n-hexyl meso-2,3-dimercaptosuccinate in mobilizing 203Hg retention in relation to age of rats and route of administration.
Kostial K; Blanusa M; Piasek M; Prester L; Jones MM; Singh PK
J Appl Toxicol; 1995; 15(3):201-6. PubMed ID: 7560740
[TBL] [Abstract][Full Text] [Related]
4. Decreasing 203Hg retention by intraperitoneal treatment with monoalkyl esters of meso-2,3-dimercaptosuccinic acid in rats.
Kostial K; Blanusa M; Simonović I; Jones MM; Singh PK
J Appl Toxicol; 1993; 13(5):321-5. PubMed ID: 8258628
[TBL] [Abstract][Full Text] [Related]
5. Prolonged oral treatment with two monoesters of meso-2,3-dimercaptosuccinic acid for depleting inorganic mercury retention in suckling rats.
Kostial K; Blanusa M; Piasek M; Jones MM; Singh PK
Pharmacol Toxicol; 1995 Sep; 77(3):216-8. PubMed ID: 8884886
[TBL] [Abstract][Full Text] [Related]
6. Reduction of lead retention by mono-3-methylbutan-1-yl meso-2,3-dimercaptosuccinate in suckling rats.
Blanusa M; Kostial K; Piasek M; Jones MM; Singh PK
Analyst; 1995 Mar; 120(3):951-3. PubMed ID: 7741262
[TBL] [Abstract][Full Text] [Related]
7. meso-2,3-dimercaptosuccinic acid monoalkyl esters: effects on mercury levels in mice.
Gale GR; Smith AB; Jones MM; Singh PK
Toxicology; 1993 Jul; 81(1):49-56. PubMed ID: 8396277
[TBL] [Abstract][Full Text] [Related]
8. Racemic-2,3-dimercaptosuccinic acid for inorganic mercury mobilization in rats.
Kostial K; Restek-Samarzija N; Blanusa M; Piasek M; Prester L; Jones MM; Singh PK
J Appl Toxicol; 1997; 17(1):71-4. PubMed ID: 9048230
[TBL] [Abstract][Full Text] [Related]
9. Combined oral treatment with racemic and meso-2,3-dimercaptosuccinic acid for removal of mercury in rats.
Kostial K; Restek-Samarzija N; Blanusa M; Piasek M; Jones MM; Singh PK
Pharmacol Toxicol; 1997 Nov; 81(5):242-4. PubMed ID: 9396091
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of monoisoamyl and monomethyl esters of meso 2,3-dimercaptosuccinic acid in gallium arsenide intoxicated rats.
Flora SJ; Mehta A; Rao PV; Kannan GM; Bhaskar AS; Dube SN; Pant BP
Toxicology; 2004 Feb; 195(2-3):127-46. PubMed ID: 14751669
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral therapy with monoisoamyl meso-2,3-dimercaptosuccinate on 203Hg retention in rats.
Kostial K; Blanusa M; Piasek M; Jones MM; Singh PK
Bull Environ Contam Toxicol; 1994 Apr; 52(4):492-7. PubMed ID: 8167441
[No Abstract] [Full Text] [Related]
12. Effect of monoisoamyl meso-2,3-dimercaptosuccinate on the pathology of acute cadmium intoxication.
Xu C; Holscher MA; Jones MM; Singh PK
J Toxicol Environ Health; 1995 Jul; 45(3):261-77. PubMed ID: 7609002
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing the efficiency of chelation therapy.
Kostial K; Kargacin B; Arezina R; Landeka M; Simonović I
J Hyg Epidemiol Microbiol Immunol; 1991; 35(4):337-50. PubMed ID: 1804865
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the protective activity of monisoamyl meso-2,3-dimercaptosuccinate against methylmercury-induced maternal and embryo/fetal toxicity in mice.
Bellés M; Sánchez DJ; Gómez M; Domingo JL; Jones MM; Singh PK
Toxicology; 1996 Jan; 106(1-3):93-7. PubMed ID: 8571406
[TBL] [Abstract][Full Text] [Related]
15. Combined chelation therapy in reducing tissue lead concentrations in suckling rats.
Kostial K; Blanusa M; Piasek M; Restek-Samarzija N; Jones MM; Singh PK
J Appl Toxicol; 1999; 19(3):143-7. PubMed ID: 10362263
[TBL] [Abstract][Full Text] [Related]
16. Effects of monoisoamyl meso-2,3-dimercaptosuccinate on arsenite-induced maternal and developmental toxicity in mice.
Domingo JL; Gómez M; Sánchez DJ; Llobet JM; Jones MM; Singh PK
Res Commun Mol Pathol Pharmacol; 1995 Sep; 89(3):389-400. PubMed ID: 8680807
[TBL] [Abstract][Full Text] [Related]
17. Methylmercury removal in the dog during infusion of 2,3-dimercaptosuccinic acid (DMSA).
Kostyniak PJ
J Toxicol Environ Health; 1983; 11(4-6):947-57. PubMed ID: 6312064
[TBL] [Abstract][Full Text] [Related]
18. Monoisoamyl meso-2,3-dimercaptosuccinate: interaction with metallothionein-bound cadmium in vitro and evidence of active transport into renal and hepatic cells in vivo.
Tasende MS; Gale GR; Smith AB; Jones MM; Singh PK
Res Commun Chem Pathol Pharmacol; 1992 Jun; 76(3):323-39. PubMed ID: 1636055
[TBL] [Abstract][Full Text] [Related]
19. [Effect of dimercaptosuccinic acid per os on distribution and excretion of 210Pb and 203Hg in mice].
Liang YY; Zhang JS; Tao ZQ; Yan XM; Xu XH; Chen ZJ
Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):379-82. PubMed ID: 7801787
[TBL] [Abstract][Full Text] [Related]
20. Antidotal efficacy of newly synthesized dimercaptosuccinic acid (DMSA) monoesters in experimental arsenic poisoning in mice.
Kreppel H; Reichl FX; Kleine A; Szinicz L; Singh PK; Jones MM
Fundam Appl Toxicol; 1995 Jul; 26(2):239-45. PubMed ID: 7589912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
